Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma
Abstract Background Hepatocellular carcinoma (HCC) is one of the most common malignant cancers worldwide, and liver cancer has increased in mortality due to liver cancer because it was detected at an advanced stages in patients with liver dysfunction, making HCC a lethal cancer. Accordingly, we aim...
Main Authors: | Sanghwa Kim, Minji Lee, Yeonhwa Song, Su-Yeon Lee, Inhee Choi, I-Seul Park, Jiho Kim, Jin-sun Kim, Kang mo Kim, Haeng Ran Seo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-021-01912-y |
Similar Items
-
The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer
by: Alexandra Giatromanolaki, et al.
Published: (2021-08-01) -
Analysis of ASS1 gene in ten unrelated middle eastern families with citrullinemia type 1 identifies rare and novel variants
by: Melissa Daou, et al.
Published: (2023-02-01) -
The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma
by: Niramol Savaraj, et al.
Published: (2007-01-01) -
Functional Characterization of Argininosuccinate Lyase Gene Variants by Mini-Gene Splicing Assay
by: Yanyun Wang, et al.
Published: (2019-05-01) -
Sinulariolide Induced Hepatocellular Carcinoma Apoptosis through Activation of Mitochondrial-Related Apoptotic and PERK/eIF2α/ATF4/CHOP Pathway
by: Yu-Jen Wu, et al.
Published: (2013-08-01)